Silk route to the acceptance and re-implementation of bacteriophage therapy - Expert round table on acceptance and re-implementation of bacteriophage therapy

Zemphira Alavidze; Rustam Aminov; Alexander Betts; Marjorie Bardiau; Laurent Bretaudeau; Jonathan Caplin; Chanishvili Nino; Aidan Coffey; Ian Cooper; Daniel De Vos

doi:10.1002/biot.201600023

Silk route to the acceptance and re-implementation of bacteriophage therapy - Expert round table on acceptance and re-implementation of bacteriophage therapy

Zemphira Alavidze, Rustam Aminov, Alexander Betts, Marjorie Bardiau, Laurent Bretaudeau, Jonathan Caplin, Chanishvili Nino, Aidan Coffey, Ian Cooper, Daniel De Vos

Research output: Contribution to journal › Article › peer-review

Abstract

This multidisciplinary expert panel opinion on bacteriophage therapy has been written in the context of a society that is confronted with an everincreasing number of antibiotic resistant bacteria. To avoid the return to a pre-antibiotic era, alternative treatments are urgently needed. The authors aim to contribute to the opinion formation of relevant stakeholders on how to potentially develop an infrastructure and legislation that paves the way for the acceptance and re-implementation of bacteriophage therapy.

Original language	English
Pages (from-to)	595-600
Number of pages	6
Journal	Biotechnology Journal
Volume	11
Issue number	5
DOIs	https://doi.org/10.1002/biot.201600023
Publication status	Published - 23 Mar 2016

Bibliographical note

© 2016 The Authors. Biotechnology Journal published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Access to Document

10.1002/biot.201600023Licence: Unspecified

Silk route to the acceptance and re-implementation of bacteriophage therapy. Sybesma_et_al-2016-Biotechnology_Journal.pdfFinal published version, 637 KBLicence: CC BY

https://onlinelibrary.wiley.com/doi/10.1002/biot.201600023Licence: Unspecified

Ian Cooper
- I.Cooperbrighton.acuk
- School of Applied Sciences - Principal Lecturer
- Centre for Regenerative Medicine and Devices
Person: Academic

Cite this

@article{723e083ff00e495bb7e9758375f03461,

title = "Silk route to the acceptance and re-implementation of bacteriophage therapy - Expert round table on acceptance and re-implementation of bacteriophage therapy",

abstract = "This multidisciplinary expert panel opinion on bacteriophage therapy has been written in the context of a society that is confronted with an everincreasing number of antibiotic resistant bacteria. To avoid the return to a pre-antibiotic era, alternative treatments are urgently needed. The authors aim to contribute to the opinion formation of relevant stakeholders on how to potentially develop an infrastructure and legislation that paves the way for the acceptance and re-implementation of bacteriophage therapy.",

author = "Zemphira Alavidze and Rustam Aminov and Alexander Betts and Marjorie Bardiau and Laurent Bretaudeau and Jonathan Caplin and Chanishvili Nino and Aidan Coffey and Ian Cooper and {De Vos}, Daniel",

note = "{\textcopyright} 2016 The Authors. Biotechnology Journal published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.",

year = "2016",

month = mar,

day = "23",

doi = "10.1002/biot.201600023",

language = "English",

volume = "11",

pages = "595--600",

journal = "Biotechnology Journal",

issn = "1860-6768",

number = "5",

}

Alavidze, Z, Aminov, R, Betts, A, Bardiau, M, Bretaudeau, L, Caplin, J, Nino, C, Coffey, A, Cooper, I & De Vos, D 2016, 'Silk route to the acceptance and re-implementation of bacteriophage therapy - Expert round table on acceptance and re-implementation of bacteriophage therapy', Biotechnology Journal, vol. 11, no. 5, pp. 595-600. https://doi.org/10.1002/biot.201600023

TY - JOUR

T1 - Silk route to the acceptance and re-implementation of bacteriophage therapy - Expert round table on acceptance and re-implementation of bacteriophage therapy

AU - Alavidze, Zemphira

AU - Aminov, Rustam

AU - Betts, Alexander

AU - Bardiau, Marjorie

AU - Bretaudeau, Laurent

AU - Caplin, Jonathan

AU - Nino, Chanishvili

AU - Coffey, Aidan

AU - Cooper, Ian

AU - De Vos, Daniel

N1 - © 2016 The Authors. Biotechnology Journal published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PY - 2016/3/23

Y1 - 2016/3/23

N2 - This multidisciplinary expert panel opinion on bacteriophage therapy has been written in the context of a society that is confronted with an everincreasing number of antibiotic resistant bacteria. To avoid the return to a pre-antibiotic era, alternative treatments are urgently needed. The authors aim to contribute to the opinion formation of relevant stakeholders on how to potentially develop an infrastructure and legislation that paves the way for the acceptance and re-implementation of bacteriophage therapy.

AB - This multidisciplinary expert panel opinion on bacteriophage therapy has been written in the context of a society that is confronted with an everincreasing number of antibiotic resistant bacteria. To avoid the return to a pre-antibiotic era, alternative treatments are urgently needed. The authors aim to contribute to the opinion formation of relevant stakeholders on how to potentially develop an infrastructure and legislation that paves the way for the acceptance and re-implementation of bacteriophage therapy.

U2 - 10.1002/biot.201600023

DO - 10.1002/biot.201600023

M3 - Article

SN - 1860-6768

VL - 11

SP - 595

EP - 600

JO - Biotechnology Journal

JF - Biotechnology Journal

IS - 5

ER -

Silk route to the acceptance and re-implementation of bacteriophage therapy - Expert round table on acceptance and re-implementation of bacteriophage therapy

Abstract

Bibliographical note

Access to Document

Fingerprint

Profiles

Ian Cooper

Cite this